RxDoctor Payments Data

Jared Gunnell, PA

Physician Assistant · Mesa, AZNPI 1366791873

Payments from drug & device makers

$3,352in general payments, 2019–2025

Across 183 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$377
  • Abbott$314
  • Lilly USA, LLC$218
  • Novo Nordisk$198
  • Boehringer Ingelheim$173
  • Johnson & Johnson$167
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,352100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,352 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$146,863
Medicare patients
631
Services billed
2,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$92,379
JardianceEmpagliflozin46$69,767
XareltoRivaroxaban38$52,804
OzempicSemaglutide25$48,533
MounjaroTirzepatide22$24,995
FarxigaDapagliflozin Propanediol19$20,888
LinzessLinaclotide29$19,450
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$6,177
Wixela InhubFluticasone Propion/Salmeterol23$3,038
Gabapentin112$2,213
Atorvastatin Calcium245$2,090
Tamsulosin Hcl172$1,909
Levothyroxine Sodium263$1,874
Albuterol Sulfate HfaAlbuterol Sulfate53$1,444
Diclofenac Sodium141$1,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$123$92,37966 claims
Boehringer IngelheimJardiance$173$69,76746 claims
Johnson & JohnsonXarelto$167$52,80438 claims
Novo NordiskOzempic$198$48,53325 claims
Lilly USA, LLCMounjaro$218$24,99522 claims
AstraZenecaFarxiga$95$20,88819 claims
AbbVieLinzess$377$19,45029 claims
Almatica Pharma LLCSertraline Hcl$18$600101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →